Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-007536
Filing Date
2025-02-24
Accepted
2025-02-24 20:38:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2985
2 EX-24 debacker-form144andsection.pdf EX-24 107787
  Complete submission text file 0001628280-25-007536.txt   153116
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Subject) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39083 | Film No.: 25658952
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address
De Backer Marianne (Reporting) CIK: 0001797819 (see all company filings)

Type: 144